OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
002886$27.3556

Shenzhen WOTE Advanced Materials Co Ltd

Commodity ChemicalsVerified

The company's capital structure is characterized by a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.42, suggesting it can cover short-term obligations but with limited buffer. The price-to-book ratio of 3.91 implies that the market values the company at nearly four times its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets. The enterprise value to EBITDA ratio of 197.23 is extremely high, suggesting the company is trading at a premium relative to its earnings before interest, taxes, depreciation, and amortization. Profitability metrics show a return on equity of 3.5% and a return on assets of 1.68%, both of which are below the typical thresholds for strong performance in the chemicals industry. The gross profit margin is 16.3% (334,412,900 / 2,051,806,370), and the operating margin is 2.1% (43,810,960 / 2,051,806,370), indicating that the company is generating modest operating profits relative to its revenue. These figures are below the median for the industry, suggesting that the company may be facing cost pressures or pricing constraints. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's primary market is China, and its operations are subject to domestic demand and supply chain dynamics. The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The capital expenditure of -104,221,890 CNY indicates a reduction in investment in physical assets, which may signal a strategic shift or financial constraints. The free cash flow of 27,838,590 CNY is positive but relatively small, limiting the company's ability to reinvest or return value to shareholders. The company's risk profile includes a medium liquidity risk, as indicated by the current ratio of 1.42 and the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential reported. However, the company's high price-to-earnings ratio of 111.78 and high enterprise value to EBITDA ratio of 197.23 suggest that the stock is overvalued relative to its earnings and cash flow, which could pose a risk if earnings do not meet expectations. Recent events include the publication of the latest financial statements, which show a net income of 64,397,170 CNY and a total equity of 1,839,830,890 CNY. The company has not disclosed any material events or strategic initiatives in the latest filings, and there are no recent transcripts from earnings calls or investor presentations that provide additional insight into the company's operations or future plans.

30-day price · 002886+7.29 (+36.3%)
Low$19.76High$27.71Close$27.35As of15 May, 00:00 UTC
Profile
CompanyShenzhen WOTE Advanced Materials Co Ltd
Ticker002886.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shenzhen WOTE Advanced Materials Co Ltd produces and sells advanced materials, primarily in the chemicals industry, generating revenue through the sale of chemical products to industrial and manufacturing customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

The company's capital structure is characterized by a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.42, suggesting it can cover short-term obligations but with limited buffer. The price-to-book ratio of 3.91 implies that the market values the company at nearly four times its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible assets. The enterprise value to EBITDA ratio of 197.23 is extremely high, suggesting the company is trading at a premium relative to its earnings before interest, taxes, depreciation, and amortization. Profitability metrics show a return on equity of 3.5% and a return on assets of 1.68%, both of which are below the typical thresholds for strong performance in the chemicals industry. The gross profit margin is 16.3% (334,412,900 / 2,051,806,370), and the operating margin is 2.1% (43,810,960 / 2,051,806,370), indicating that the company is generating modest operating profits relative to its revenue. These figures are below the median for the industry, suggesting that the company may be facing cost pressures or pricing constraints. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's primary market is China, and its operations are subject to domestic demand and supply chain dynamics. The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The capital expenditure of -104,221,890 CNY indicates a reduction in investment in physical assets, which may signal a strategic shift or financial constraints. The free cash flow of 27,838,590 CNY is positive but relatively small, limiting the company's ability to reinvest or return value to shareholders. The company's risk profile includes a medium liquidity risk, as indicated by the current ratio of 1.42 and the negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential reported. However, the company's high price-to-earnings ratio of 111.78 and high enterprise value to EBITDA ratio of 197.23 suggest that the stock is overvalued relative to its earnings and cash flow, which could pose a risk if earnings do not meet expectations. Recent events include the publication of the latest financial statements, which show a net income of 64,397,170 CNY and a total equity of 1,839,830,890 CNY. The company has not disclosed any material events or strategic initiatives in the latest filings, and there are no recent transcripts from earnings calls or investor presentations that provide additional insight into the company's operations or future plans.
Key takeaways
  • The company has a high price-to-earnings ratio of 111.78, indicating that the stock is overvalued relative to its earnings.
  • The company's return on equity of 3.5% is below the typical threshold for strong performance in the chemicals industry.
  • The company's liquidity position is assessed as medium, with a current ratio of 1.42.
  • The company's revenue is concentrated in a single business segment, increasing exposure to regional economic fluctuations.
  • The company's capital expenditure is negative, indicating a reduction in investment in physical assets.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$2.05B
Gross profit$334.4M
Operating income$43.8M
Net income$64.4M
R&D
SG&A
D&A
SBC
Operating cash flow$221.2M
CapEx-$104.2M
Free cash flow$27.8M
Total assets$3.83B
Total liabilities$1.99B
Total equity$1.84B
Cash & equivalents
Long-term debt$1.44B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$2.05B$43.8M$64.4M$27.8M
FY-1$1.90B$37.6M$36.6M-$132.5M
FY-2$1.54B$14.8M$5.9M-$295.7M
FY-3$1.49B$15.2M$14.6M-$405.6M
FY-4$1.54B$70.6M$63.2M-$320.5M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$3.83B$1.84B
FY-1$3.78B$1.78B
FY-2$3.20B$1.76B
FY-3$2.66B$1.17B$161.3M
FY-4$2.14B$1.16B
PeriodOCFCapExFCFSBC
FY0$221.2M-$104.2M$27.8M
FY-1$93.8M-$231.5M-$132.5M
FY-2$52.7M-$358.3M-$295.7M
FY-3$119.4M-$443.2M-$405.6M
FY-4-$23.5M-$404.3M-$320.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$460.7M$10.0M$13.0M
FQ-1$637.3M$20.3M$34.3M
FQ-2$508.2M$10.5M$11.7M
FQ-3$511.5M$11.3M$12.3M
FQ-4$394.8M$1.7M$6.1M
FQ-5$609.5M$7.8M$11.5M
FQ-6$480.3M$12.6M$10.2M
FQ-7$443.2M$10.4M$9.4M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$3.75B$1.85B$355.5M
FQ-1$3.83B$1.84B
FQ-2$3.86B$1.80B$266.5M
FQ-3$3.84B$1.79B
FQ-4$3.78B$1.78B$341.0M
FQ-5$3.78B$1.78B
FQ-6$3.64B$1.77B$228.8M
FQ-7$3.42B$1.75B
PeriodOCFCapExFCFSBC
FQ0$34.1M-$15.6M
FQ-1$221.2M-$104.2M
FQ-2$95.9M-$80.0M
FQ-3$64.0M-$49.7M
FQ-4$15.5M-$26.5M
FQ-5$93.8M-$231.5M
FQ-6$83.0M-$213.1M
FQ-7$34.1M-$146.0M
Valuation
Market price$27.35
Market cap$7.20B
Enterprise value$8.64B
P/E111.8
Reported non-GAAP P/E
EV/Revenue4.2
EV/Op income197.2
EV/OCF39.1
P/B3.9
P/Tangible book3.9
Tangible book$1.84B
Net cash-$1.44B
Current ratio1.4
Debt/Equity0.8
ROA1.7%
ROE3.5%
Cash conversion3.4%
CapEx/Revenue-5.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002886Activity
Op margin2.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin3.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin16.3%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-5.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity78.0%59.0% medp25 54.9% · p75 72.9%top quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:29 UTCJob: 95a62d58